Stromal Cells Are the Main Plasminogen Activator Inhibitor-1-Producing Cells in Human Fat
- 1 January 2002
- journal article
- other
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 22 (1) , 173-178
- https://doi.org/10.1161/hq0102.101552
Abstract
Elevated plasma plasminogen activator inhibitor (PAI)-1 observed during insulin resistance has been connected with an excessive PAI-1 adipose tissue secretion mainly by visceral fat. Our aim was to compare the localization of PAI-1 in human visceral and subcutaneous fats. PAI-1 secretion was also investigated in vitro during human adipocyte differentiation. PAI-1 antigen and mRNA were localized in the stromal area of the tissue and were also present in a few CD14-positive monocytes, in direct contact with adipocytes. In addition, in subcutaneous tissue, PAI-1 mRNA contents, determined by using real-time polymerase chain reaction, were higher in the stromal fraction than in the adipocyte fraction. PAI-1 mRNA-positive cells were 5-fold more frequent in the visceral area than in the subcutaneous stromal area ( P =0.004). Such a difference was also observed for PAI-1 mRNA content between both whole adipose tissues. In contrast to leptin, during adipocyte differentiation, PAI-1 secretion did not follow adipocyte maturation. In situ hybridization in culture did not reveal PAI-1 mRNA in lipid-filled cells. Our results demonstrate that PAI-1 production is mainly due to stromal cells, which were more numerous in the visceral than in the subcutaneous depot. These results could explain the strong relationship observed between circulating PAI-1 levels and the accumulation of visceral fat.Keywords
This publication has 18 references indexed in Scilit:
- Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.Diabetes, 2000
- Synthesis and Secretion of Plasminogen Activator Inhibitor-1 by Human PreadipocytesJournal of Clinical Endocrinology & Metabolism, 1999
- Tumor necrosis factor α is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1Proceedings of the National Academy of Sciences, 1999
- Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-α?Atherosclerosis, 1999
- Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in womenInternational Journal of Obesity, 1998
- Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individualsDiabetologia, 1998
- Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular DiseaseDiabetes, 1997
- Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeistyNature Medicine, 1996
- Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide.Journal of Clinical Investigation, 1996
- Quantitative image analysis for immunocytochemistry and in situ hybridizationJournal of Neuroscience Methods, 1994